and peritubular and mesangial cells in kidney. Microglial cells and osteoclasts also labelled with EBM/1 1. The antibody reacted with cytoplasmic structures rather than with cell membranes. The epitope recognised by EBM/l I was present on four polypeptides (of 120, 70, 64 and 22 kilodaltons). It did not react with any other cell type in the tissues screened except the epithelium of renal proximal tubules.
This antibody may be useful in identifying and elucidating the function of macrophages in pathological processes.
There is a need for reliable and sensitive reagents for the identification of human macrophages, particularly in studies of lymphoproliferative disease, the immune response, inflammation and neoplasia. To this end a-1-antitrypsin (al-AT),' lysozyme,2 peanut agglutinin (anti-T lectin),3 and non-specific esterase4 have been used as specific markers for macrophages. All of these, however, are found in cells which are manifestly not macrophages. For example, a 1-AT is present not only in macrophages but also in polymorphs5 and in hepatocytes. 6 Several monoclonal antibodies to macrophages/monocytes have been produced to overcome the shortcomings of histochemical methods for macrophage/monocyte identification.7 Most of these have been used in studies of isolated monocytes but it is clear that many of them label cells other than macrophages/monocytes.9 ' The aim of this study was to produce monoclonal antibodies to macrophages and to determine their specificity for this cell type. The long term objective was to use these reagents with high specificity for macrophages to High cellular specificity ofEBMIII for macrophages concentrated at the interface were removed, washed, and resuspended at 106 cells/ml in L-1 5 medium, and placed in 80 cm2 culture flasks (Nunc, Denmark) in 80 ml of RPM1 1640 medium supplemented with 5% fetal calf serum, benzylpenicillin (100 p/ml), streptomycin (100 i/ml), and gentamycin (80 p/ml). After incubation in a 5% carbon dioxide and 95% oxygen atmosphere for one hour at 37°C the adherent monolayer was agitated and washed gently with two changes of the same medium, thus affording virtually pure macrophage monolayers. Macrophages were detached from the plastic with a sterile rubber policeman. With very fresh lung specimens, a total yield of 6 x 106 adherent macrophages/50 g of lung tissue was typical, though with lung samples of up to four or five hours old (transported in L-1 5 medium) the total yields were typically reduced to 3 x 106 adherent macrophages/50 g lung. These macrophages were judged viable according to their ability to exclude trypan blue.
MONOCLONAL ANTIBODY PRODUCTION AND SCREENING
About 107 purified macrophages in 0 2 ml Hanks's balanced salt solution (BSS) were mixed with an equal volume of complete Freund's adjuvant and injected subcutaneously into Balb C mice. The animals received three intraperitoneal booster doses of 107 cells in 0 2 ml of BSS, without adjuvant, at two week intervals. Three days after the final injection separated mouse spleen cells (about I o8 cells) were filtered through a sterile stainless steel strainer and fused with 107 mouse myeloma cells (NSI) using 50% polyethylene 4000 (BDH, UK) in RPMI 1640 medium; the cell suspension was agitated for 90 seconds and incubated for a further five minutes at 22°C." After immediate washing with RPM 1 1640 containing hypoxanthine, methotrexate, and thymidine (HAT) the cells were resuspended in 50 ml of RPM 11640 containing HAT and 10% fetal calf serum, and plated into Costar wells." This method afforded between 300 and 400 hybrid colonies. Two hundred of these colonies were separated, subcloned, grown and frozen in liquid nitrogen.
As a primary screen for macrophage reactive antibodies culture supernatants were tested by an indirect immunoperoxidase procedure'2 on cryostat sections of human lung and tonsil fixed at -20°C in acetone for 10 minutes. The cells from those supernatants, which stained lung or tonsil macrophages, or both, were definitively cloned by dilution cloning using either Terasaki microtitre plates or round-bottom (300 p1) 96 well plates with mouse spleen feeder cells at 106/ml." The supernatants from these clones were tested immunohistochemically for antimacrophage specificity, on a second more extensive organ screen. This consisted of acetone fixed (-20°C for 20 511 minutes) cryostat sections of normal lung, tonsil, lymph node, spleen, liver, pancreas, stomach, small and large bowel, gall bladder, kidney, heart, brain, pituitary, thyroid, placenta, and skin. Cytocentrifuged buffy coat cells from human peripheral blood and isolated lung macrophages fixed in acetone were also included in this secondary screen. All tissues and cells used in this secondary screen were obtained fresh at biopsy, or from necropsy organs within 24 hours of death.
Immunohistochemical controls consisted of tissues or cells treated with culture medium alone, or irrelevant monoclonal antibodies to Mallory's bodies'" (JMBI, JMB2), followed by rabbit antimouse Ig conjugated with peroxidase (Dako, UK), or, in a few instances, rabbit antimouse followed by alkaline phosphatase-mouse antialkaline phosphatase complex. The conditions for immunohistochemical analysis are as described,'2 except that after the application of primary antibody (or control antibody) sections or cells for immunoperoxidase staining were treated for 30 minutes with methanol containing 1% H202 (v/v) at 22°C and washed in PBS before incubation with second antibody. In some tissues the reaction of EBM/1 1 was detected using the alkaline phosphatase-antialkaline phosphatase method using a standard procedure. '2 The immunoglobulin class of interesting monoclonal antibodies was determined by the Ouchterlony method using subclass specific antisera (Dako, UK).
WESTERN BLOTS
Lung macrophages were isolated and maintained for four to 24 hours in L-1 5 medium supplemented with antibiotics (see above) and 10% heat inactivated fetal calf serum. Cultures were washed twice in Hanks's BSS, harvested with a rubber policeman, and the macrophages recovered by centrifugation at 1500 g for five minutes. The cell pellet was dispersed in a minimum volume of a buffer solution containing Triton-X 100 (0 1%), 5 mmol/l edetic acid, 0-01 mmol/l Tris-hydrochloric acid, 2 mmol/l phenylmethylsulphonfluoride, 2 5 mmol/l iodoacetamide of pH 7 4.
The cell suspension was sonicated for 30 seconds and centrifuged at 1500 g for 15 minutes. Ten volumes of absolute ethanol were added to the supernatant, incubated at 22°C for five minutes, and the precipitated protein recovered by centrifugation (12 000 g for five minutes). The pellet was dissolved at 80°C for five minutes in 5% sodium dodecyl sulphate (SDS) containing 2% mercaptoethanol. Proteins were electrophoresed on 7-5% polyacrylamide gels in an electrophoresis buffer containing 80 mmol/l Tris, 50 mmol/l boric acid, and 0 1% SDS at pH 8 5; molecular weight standards were run on each gel. Proteins were transferred (in an electric field for 16 hours) to nitrocellulose filters (0.45 pm pore size) using a buffer ,''* w^4.
,.i'X,X~~~~~~~1m7 (fig 7) .
The antibody also stained stellate mononuclear cells (presumptive macrophages) in the stroma of invasive breast cancers'9 but not the neoplastic epithelial cells The screening procedure used here for the generation of EBM/1 1 is instructive. Although 20 monoclonal antibodies were produced which reacted with the primary immunogen (lung macrophages), only one of these showed high cellular specificity for cells of the mononuclear/phagocyte system. This emphasises the importance of screening monoclonal antibodies agaitst large numbers of intact tissues before claims are madefor cellular specificity. We have shown in this paper that EBM/ 1I labels known or presumptive cells of the human mononuclear/phagocyte system in normal tlssues with a high degree of specificity.
It has also been shown to label multinucleate cells in giant cell myocarditis'7 and in giant cell tumour of bone,26 the tumour cells in a single case of malignant histiocytosis (unpublished observations), and also presumptive macrophages in human breast cancer (fig 8) .' There has been controversy about the nature of these cells in these various diseases." 26 We believe that the demonstration of the shared relatively specific EBM/1 1 positive immunophenotype between these cells and normal mononuclear/phagocyte system cells has contributed to the understanding of these diseases and that this antibody will assist in the study of other disease processes in man.
